INTRODUCTION
Fulminant Acute Hepatitis (FAH) is a serious and dynamic clinical syndrome characterized by the quick worsening of hepatic function in patients without a history of liver disease.
1. 2 Both the epidemiology and etiology of FAH are little known, especially in pediatrics. It has several causes, the main ones being acetaminophen poisoning, infections (especially viral ones), metabolic diseases, autoimmune diseases, among others.
The interval between the onset of symptoms and hepatic encephalopathy has determined different definitions for FAH.
2. 3 Although these definitions may differ in some clinical aspects, in clinical practice, they are usually not used. Actually, hepatic en-Caribbean and identify possible measures aiming at a better understanding and the improvement of the patient support.
METHODS
For the selection of the articles analyzed in this review, the PubMed and SciELO databases were searched by three different researchers (JCJ, RT, and FC), as shown in Figure 1 .
We included studies of the following modalities: prospective or retrospective cohort, papers of systematic and non-systematic review and clinical trials, case reports, and case series containing a description of patients with HAF with a maximum age of 18 years. Only studies available in Portuguese, English, or Spanish were considered.
In the search mechanisms, the following terms were used: acute OR fulminant AND liver OR hepatic AND failure in the PubMed database and acute liver failure/falla hepática aguda in the SciELO database. We used three filters: for languages (English, Portuguese and Spanish), age (pediatrics), and date of the study (from 2000 up to 2016). All references were checked to decrease the possibility of excluding any relevant studies. cephalopathy (HE) can be subtle in pediatric patients with FAH or may not even manifest until the end stage of the disease, which makes it not essential for the clinical diagnosis.
It is estimated that spontaneous recovery occurs in only 15-20% of patients with HE 4 and that FAH is responsible for 10-15% of all pediatric liver transplants. 5 Due to the absence of therapies that effectively restore hepatocyte function or promote its regeneration, the support treatment is one of the few options before liver transplantation.
6. 7 The prognosis is determined based on the complications caused by acute liver failure (ALF), including cerebral edema, sepsis, and multiple organ dysfunction.
Considering the great heterogeneity of causes, the few possibilities of effective treatments after the IHA and the frequent complications from HAF, preventive measures are still the primary means of reducing morbidity and mortality. 8 In this context, the countries of Latin America and the Caribbean comprise a list of countries with low to medium Human Development Index, and preventive measures about FAH could be implemented to reduce its incidence.
9
The objective of this review was to investigate the epidemiology of FAH in Latin America and the We adopted the following exclusion criteria: duplicate studies, editorials in journals, book chapters, papers retrieved by the search terms but which no relation to the subject of the review, studies in adult patients, experimental studies, and articles not related to the Latin America and Caribbean regions.
The data obtained were entered into tables, and the sum of the columns and the averages were calculated. The chi-square test and the Student's t-test were used for statistical analysis.
RESULTS
We found 2,879 articles in the databases searched. After the initial selection, we evaluated the titles or abstracts and removed 2,785 papers based on the exclusion criteria; a total of 92 publications were left for evaluation. After further verification, we excluded another 24 articles (8 duplicates and 16 not related to the topic of the study). As a result, there were 68 remaining studies for analysis.
10-77
Of the studies analyzed, 34 were published in international journals and 34 in national journals of their respective countries. In total, we evaluated FAH 1,265 cases, with a predominance in females (42.9%), followed by males (39.4%); in 17.7% of cases, there was no description of sex.
The virus, especially those of hepatitis, were the main causes for ALF, in 45.1% of the cases. The hepatitis A virus was responsible for 34.7% of the total number of cases and 76.9% of infectious causes. Other viruses such as parvovirus, herpes, cytomegalovirus, Epstein-Barr, dengue, and rubella were also described. Of the total of patients, 340 (26.9%) were described as idiopathic, and 145 (11.5%) had no cause described. Table 1 shows the distribution of infectious HAF per country of origin. We found 62 cases (4.9%) of autoimmune diseases, and poisoning accounted for 3.4% of cases, the most common being poisoning by fireworks (27.9%), followed by the use of isoniazid (16.3%). Paracetamol was reported in only 0.2% of all cases of ALF and in 4.6% of the drug causes.
The countries that had the most published articles on FAH were Brasil (30.4%), Chile (24.3%), and Argentina (18.8%). Reports were also found from the following countries: Peru, Uruguay, Colombia, Costa Rica, Mexico, and Cuba.
Other data found also refers to the number of deaths and transplant patients. There were a total of 326 deaths reported (25.8% of cases) and 634 transplant patients (50.1% of cases).
The main studies, with their objectives, number of patients, and results are listed in Table 2 .
DISCUSSION
This is the first review of the epidemiological aspects of FAH in the Latin America and Caribbean regions. With the results obtained, we evaluated the importance of VH in the causes of ALF. Although some of them are preventable by vaccination, VHs are the main infectious agents that cause FAH in the regions assessed, representing 94.3% of all cases described in this study, followed by yellow fever (2.3%), and cytomegalovirus (1.5%).
FAH secondary to VH has as its predominant cause the type A virus (HAV), representing 76.9% of all infectious causes; Argentina alone is responsible for 61.0% of all HAV cases. This reality seems to be changing after the introduction of HAV vaccination on a large scale in the country in 2005. 78 Since 2006, there was a 88.1% decrease compared to the period prior to the vaccination. Also were also no cases of FAH not notified in the country, nor the need for liver transplantation due to HAV since March 2007.
79
It should be noted that, way behind HAV infection, there are also infections by the type E virus (6.7%), and type B (5.3%), which could indicate the effectiveness of the Type B VH vaccination, which used to be more prevalent and nowadays is a rare cause of FAH.
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The country with the highest number of cases described was Argentina, with 53.6% of all infectious HAF, followed by Brasil (25.4%), and Chile (12.8%). These data lead to the question: Do these numbers reflect the reality in these regions studied or just the publication capacity of researchers from each country? Regardless, these data provide important information on the causes of FAH in Latin American and Caribbean countries with potentially preventable diseases, thus providing the possibility of planning effective measures that can contribute to the reduction of morbidity and mortality.
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Among the drug or poisoning causes, we found a different reality from the one reported in other countries such as the United States and the United Kingdom, where paracetamol is the main agent of drug-induced FAH and mushrooms can cause enough poisoning to produce FAH.
4. 82 In Latin America and the Caribbean, paracetamol appeared in only two out of a total of 43 cases. Surprisingly, fireworks were the main etiology of FAH in patients suffering from exposure to its chemical agents, especially yellow phosphorus.
54
Considering the other causes, a considerable number of FAH cases due to autoimmune diseases appears in this review. There were 62 cases (4.9% of the total), and Brasil (28 cases) and Argentina (16 cases) were responsible for the majority of the cases reported. There is also a large number of cases classified as idiopathic. There was a total of 340 cases classified this way (26.9% of the total), in addition to 145 cases with no cause described, which proves the difficulty of performing more complex etiological diagnosis in the pediatric age range, only notifying the most common infectious causes.
8.83
Another important data found in this study concerns the outcome of FAH cases submitted to liver transplantation (LT). Only half of the patients (50.1%) was submitted to LT, which might reflect the low mortality rate found (25.8% of cases).
7
Considering the population of the regions studied (Latin America and the Caribbean), we found a number of articles below expected, comprised mostly of case reports or case series and regional studies in a single center. We noticed the absence of multicenter studies of greater impact, which could best contribute to the review.
CONCLUSION
The avoidable causes of Fulminant Acute Hepatitis in Latin America and the Caribbean include the hepatitis viruses -especially hepatitis A -and poisonings. The active vaccination, basic sanitation, and public awareness can reduce the number of FAH patients and, consequently, the costs with the LT due to these causes. Paracetamol does not represent an emerging cause of FAH in this region, according to this review. Moreover, the high number of patients with idiopathic HAF or with no cause described draws attention and should guide public health efforts for the better elucidation of the epidemiology of FAH. 
